Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Resources
Registration
Abstract & Program Guides
CE Credits
Mobile App & TLMdX
Schedule
Speakers
About
AASLD Foundation
AASLD Members
First Time Attendee
Global Programming
Access TLMdx
Hyman J. Zimmerman Hepatotoxicity State of the Art: Systemic Therapy for Hepatocellular Carcinoma in 2025—Where Are We Now?
Nov
09
2025
Convention Center: Hall A (General Session), Concourse Level
11:00 AM - 11:30 AM
World Class Speakers
Presenter
Laura M Kulik, MD
Northwestern Medical Faculty Foundation
Moderator
David E Kaplan, MD, MS, MSc, FAASLD, FACP, AGAF
University of Pennsylvania
Description
Laura Kulik, MD
will present the Hyman J. Zimmerman Hepatotoxicity State of the Art Lecture, "Systemic Therapy for Hepatocellular Carcinoma in 2025: Where Are We Now?"
Journey Maps
Liver Cancer
Presentations
1:28 PM - 1:28 PM
Nov
09
2025
Washington, D.C.
Systemic Therapy for Hepatocellular Carcinoma in 2025: Where Are We Now?
Laura M Kulik, MD, Presenter
Liver Cancer
1:28 PM - 1:28 PM
Nov
09
2025
Washington, D.C.
Introduction
David E Kaplan, MD, MS, MSc, FAASLD, FACP, AGAF, Moderator
Liver Cancer
Objectives
Discuss the latest developments in the use of systemic therapy to treat hepatocellular carcinoma.